Hoeprich P D, Lawrence R M, Goldstein E
JAMA. 1980 May 16;243(19):1923-6.
Miconazole was injected intravenously in six patients with coccidioidomycosis. Two patients received 101 and 185 g, respectively, without clinical response and with persistence of positive cultures for Coccidioides immitis. In one patient, symptoms were suppressed when amphotericin B was given with miconazole, but new lesions developed with miconazole alone (total dose, 963 g). Three patients received smaller doses: 30.6 g before death from an unrelated complication; 17 and 22.3 g before development of severe allergic reactions. Because of the high rate of initial failures and relapses, miconazole is not recommended as primary therapy for coccidioidomycosis.
对6例球孢子菌病患者静脉注射咪康唑。2例患者分别接受了101克和185克的剂量,无临床反应,粗球孢子菌培养仍呈阳性。1例患者在两性霉素B与咪康唑联合使用时症状得到缓解,但单独使用咪康唑(总剂量963克)时出现了新的病灶。3例患者接受了较小剂量:1例在死于无关并发症前接受了30.6克;另外2例在出现严重过敏反应前分别接受了17克和22.3克。由于初始治疗失败率和复发率较高,不推荐将咪康唑作为球孢子菌病的一线治疗药物。